VRTX: Wutah pendapatan triwulanan Vertex Pharmaceuticals

Vertex Pharmaceuticals (VRTX) - logo korporat

Vertex Pharmaceuticals (VRTX) profitability relies on revenues from cystic fibrosis treatment, which creates dependency risks. The quarterly revenue growth rate on GURU.Markets is available for analysis, where the 10.20 indicator expresses the state of the metric. The company's leadership is based on the radical correction of genetic defects. Financial stability is gradually strengthening through the implementation of gene therapy, neutralizing regulatory pressure.

VRTX Tambahing pendapatan triwulanan Vertex Pharmaceuticals Inc. (04.07.2022 - 20.11.2026)

Ringkesan rincian data analitis Vertex Pharmaceuticals Inc. (VRTX)

Pambiji fundamental perusahaan:Vertex Pharmaceuticals Incorporated (VRTX)
Produk sing diprodhuksi Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals utilizes a production outsourcing model, making the quarterly sales growth rate a key indicator of the commercialization efficiency of its scientific developments under low capital expenditures. This metric captures the percentage change in revenue compared to the same period last year, revealing an acceleration or deceleration in operational dynamics. Analysis of this chart allows for the differentiation between a phase of active growth and business stagnation. Purchasing the asset at the peak of this indicator risks overpaying for a slowing pace of expansion.

Pesaing utama

Alnylam Pharmaceuticals - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan INSM (Insmed Incorporated)|UTHR: Wutah pendapatan triwulanan|BioMarin Pharmaceutical Inc. (BMRN) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BridgeBio Pharma Inc|Wutah dodolan triwulanan BGM Group Ltd (BGM)|Wutah pendapatan kuartal marang kuartal cogentbio.com (COGT)|Wutah dodolan triwulanan Xeris Biopharma XERS|Wutah pendapatan triwulanan KROS (kerostx.com)|Wutah pendapatan triwulanan Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah pendapatan triwulanan|KMDA - Wutah pendapatan triwulanan|FULC (Fulcrum Corp) - Wutah dodolan triwulanan|ABEO (Abeona Therapeutics, Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PLRX|Wutah pendapatan kuartal marang kuartal APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah dodolan triwulanan|Gelteq Limited (GELS) - Tingkat wutah pendapatan sajrone kuartal|aytubio.com - Wutah pendapatan triwulanan|chemomab.com (CMMB) - Wutah dodolan triwulanan|SRXH: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal PLRZ (Polyrizon Ltd.)|Wutah dodolan triwulanan AEZS|CYTH: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal inozyme.com (INZY)|Wutah pendapatan triwulanan Reneo Pharmaceuticals Inc. (RPHM)|Wutah pendapatan triwulanan CSCI (Aeterna Zentaris)